Jose Hernandez

[Cristina Tejera @cristinatejerap]

Llevamos años obsesionados con bajar los triglicéridos. Nueva revisión ➡️los TG no son directamente aterogénicos. Son el marcador de las lipoproteínas remanentes ricas en TG, que sí entran en la pared arterial. 🫀
Lo importante no es la cifra, es la carga de partículas apo B

@ESC_Journals

🔗 https://t.co/PfieuYrQSa

[Jose Hernandez @Pharma_Mty]

@_alynana Cenas y te vas

[Dr. Hardik Patel 🩺💉 @hardik4u24]

💊RAAS inhibitors work across the CKD spectrum🫘

✅Slow CKD progression
❤️Reduce CV events (esp with albuminuria)
🛅Preserve residual kidney function on HD
🫘Improve transplant outcomes

Start early, monitor well & keep RAASi on board whenever possible

🔗https://t.co/rsTghZVk73

[Henry Han @HanCardiomd]

Brain mineralocorticoid receptor activation and antagonism in #HFpEF: a hypothesis

Hypothetical mechanistic on #MRA as potentially more effective than #nsMRAs regarding #stroke and cognitive impairment in patients with #HFpEF

https://t.co/l1AFGEHVCs

#EHJ @escardio @AndrewJSauer @SJGreene_md @gcfmd @ShelleyZieroth

[Antonio García-Hermoso @a_garciahermoso]

🫀⏳Las múltiples enfermedades cardiometabólicas crónicas no aparecen de golpe: se construyen desde el útero y la infancia.

Obesidad infantil, resistencia a la insulina y adversidad social pueden abrir una trayectoria de riesgo👶➡️👵

Prevenir = salud ✅

https://t.co/74nfHHCjyt

[American College of Cardiology @ACCinTouch]

Adults with congenital heart disease may experience accelerated biological aging, explaining earlier onset of frailty, cognitive decline & other age-related challenges. 🆕ACC Expert Analysis explores the potential mechanisms of aging.🔗https://t.co/Cb5ogYXOQ2

#CHD #ACHD #ACCACPC

[Ahmed Bennis MD 🫀 @drbennisahmed]

Trends in nephrology: from “supportive care” to CKD combination therapy

The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD emphasizes patient-centered, team-based management integrating these therapies.

https://t.co/j2Jzcgiw36

[Ahmed Bennis MD 🫀 @drbennisahmed]

Polypill for heart failure with reduced ejection fraction: the POLY-HF randomized trial

A polypill for heart failure was associated with a significant improvement in cardiac function as compared with enhanced usual care.
@gcfmd @SJGreene_md

https://t.co/f8lRRV5rah

[Ahmed Bennis MD 🫀 @drbennisahmed]

Albuminuria and heart failure

Clinical trials of guideline-directed therapies, RAASi , SGLT 2 inhibitors and finerenone show that reductions in urinary albumin-to-creatinine ratio is associated with risk reductions for CV , heart failure, and CKD

https://t.co/owuQKgr4uF

[Sociedad Española de Patología Digestiva (SEPD) @sepdigestiva]

Un mayor índice de masa corporal (IMC) se asocia con un mayor riesgo de desarrollar, al menos, 19 tipos de cáncer y con un menor riesgo de algunos otros. https://t.co/GG0mCHAXgX

[Ahmed Bennis MD 🫀 @drbennisahmed]

Contemporary Management of Acute Heart Failure: From Emergency Presentation to Long-Term Remission

The goal is to outline an integrated, holistic, and patient-centered care pathway to facilitate timely recognition and access to GDMT for AHF
@JACCJournals
https://t.co/0paseM2jo3

[Marcos Gamboa @mrcsgmb84]

El Síndrome Cardiorrenometabólico (SCRM) exige un cambio radical en nuestra mentalidad clínica. Ya no podemos tratar el coraz��n, el riñón y el páncreas como islas. El SCRM es una interacción fisiopatológica continua impulsada por la inflamación sistémica. 🧵 ⬇️@Diabetes_SEMI @redGDPS @sociedadSEEN @cristinatejerap @CristobMorales @fjavesc @IcyfaSemi @SLANH_ @SENefrologia @PepaSolerR @drdargaray @JonathanNefro @PerlaZambrano

[American College of Cardiology @ACCinTouch]

A novel sarcopenic obesity index served as a clinically meaningful predictor of cardiovascular risk and lent further insight into accompanying genetics and possible therapeutic targets.

Learn more ↪️ https://t.co/79I79MI4Ny #JACC

[Amelia Carro — Instituto Corvilud @icorvilud]

UACR: urinary albumin to creatinine ratio
📌Gold standard tool to detect early kidney damage
🫀Cardiovascular risk indicator
⚠️Highly recommended:
. Diabetes
. Obesity
. High blood pressure
. CVD/CV risk
💊Can be targeted
. ARAII
. SGLT2i
. GLP1
. Finerenone
⚠️WHY SO UNDERUSED?

[Nature Metabolism @NatMetabolism]

COMMENT | L Khoo & R Barzilay (MIT)

Why machine learning fails at mass spectrometry for small molecules

https://t.co/Jyv5ePCqqe

[Diego Segura-Rodríguez @SeguraCardio]

📌Management of 👥 at Risk of Ischemic Stroke w/ Left Ventricular Systolic Dysfunction in the Absence of Intracardiac Thrombus

A Scientific 📝 from the @American_Heart

#PositionPaper #Stroke #LVSD #HF

[Jose Hernandez @Pharma_Mty]

@iJuanMartinez @AlessandraRdlv Ella va a ser la culpable de todo…

[Jose Hernandez @Pharma_Mty]

@deriniko9 Polonia

[Endotips @endotips]

Fármacos que interfieren con la absorción y metabolismo de la levotiroxina.

Treatment-refractory hypothyroidism: Don’t just increase the dose.

📚 Cleveland Clinic Journal of Medicine - 2026.
doi: https://t.co/rXguL4MxMK

[Jose Hernandez @Pharma_Mty]

@Mercado_Ingles ?¿Y eso no es dopping? Están mejorando sus habilidades físicas